Approval · Notice of Compliance 8024 · 2006
TOBI: Notice of Compliance 8024
Issued June 13, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8024
- Date
- June 13, 2006
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Respiratory antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOBI | 02239630 | Marketed |
Medicinal ingredients
- TOBRAMYCIN SULFATE 300 MG per 5ML